Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 29,455 | 43,293 | 42,697 | 48,148 | 34,658 |
| Gross Profit | 29,455 | 43,293 | 42,697 | 48,148 | 34,658 |
| Operating Expenses | 34,308 | 33,655 | 24,101 | 26,138 | 23,712 |
| Operating Income | -4,853 | 9,638 | 18,596 | 22,011 | 10,946 |
| Other Income | 2,180 | 2,241 | 1,740 | 1,886 | 1,091 |
| Pre-tax Income | -2,673 | 11,879 | 20,336 | 23,897 | 12,037 |
| Net Income Continuous | -2,673 | 11,705 | 20,336 | 23,897 | 12,037 |
| Net Income | $-2,673 | $11,705 | $20,336 | $23,897 | $12,037 |
| EPS Basic Total Ops | -0.03 | 0.13 | 0.21 | 0.25 | 0.13 |
| EPS Basic Continuous Ops | -0.03 | 0.12 | 0.21 | 0.25 | 0.13 |
| EPS Diluted Total Ops | -0.03 | 0.11 | 0.21 | 0.24 | 0.13 |
| EPS Diluted Continuous Ops | -0.03 | 0.11 | 0.21 | 0.24 | 0.13 |
| EBITDA(a) | $-3,416 | $11,107 | $19,951 | $23,674 | $11,967 |